Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic ITP as a model for immunization by platelets.

R McMillan1

  • 1Department of Basic and Clinical Research, Research Institute of Scripps Clinic, La Jolla, California 92037.

Progress in Clinical and Biological Research
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in voluntary running behavior between C57BL/6 and BALB/cJ mouse strains do not correspond to changes in VO2 and RER.

Physiological reports·2025
Same author

Validation of an Oral Disease Severity Score (ODSS) tool for use in oral mucous membrane pemphigoid.

The British journal of dermatology·2019
Same author

Day-case holmium laser enucleation of the prostate: feasibility, safety and predictive factors.

Annals of the Royal College of Surgeons of England·2018
Same author

An Oral Disease Severity Score validated for use in oral pemphigus vulgaris.

The British journal of dermatology·2018
Same author

Orofacial pain - an update on diagnosis and management.

British dental journal·2017
Same author

2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.

Leukemia & lymphoma·2016
Same journal

DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.

Progress in clinical and biological research·2018
Same journal

Endotoxin and sepsis: molecular mechanisms of pathogenesis, host resistance, and therapy. Proceedings of the 4th Conference of the International Endotoxin Society. Nagoya, Japan, October 23-27, 1996.

Progress in clinical and biological research·1998
Same journal

The pathogenic role of LBP in gram-negative sepsis and septic shock.

Progress in clinical and biological research·1998
Same journal

The role of interleukin 6 in endotoxin-induced inflammatory responses.

Progress in clinical and biological research·1998
Same journal

Role of nitric oxide and reactive oxygen species in endotoxin shock.

Progress in clinical and biological research·1998
Same journal

Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.

Progress in clinical and biological research·1998
See all related articles

Immune thrombocytopenia (ITP) is an autoimmune disorder where autoantibodies target platelet glycoproteins, leading to platelet destruction. The exact cause of this immune system defect remains unknown.

Area of Science:

  • Immunology
  • Hematology
  • Autoimmune Diseases

Background:

  • Immune thrombocytopenia (ITP) is characterized by autoantibodies against platelet glycoproteins.
  • These autoantibodies bind to platelets and megakaryocytes, initiating immune responses.

Purpose of the Study:

  • To summarize the immunological mechanisms underlying Immune thrombocytopenia (ITP).
  • To highlight the current understanding of autoantibody involvement in ITP pathogenesis.

Main Methods:

  • Review of existing literature on ITP pathophysiology.
  • Analysis of autoantibody binding and its consequences on platelets and megakaryocytes.

Main Results:

  • Autoantibodies in ITP primarily target platelet membrane glycoproteins.

Related Experiment Videos

  • Antibody binding triggers platelet phagocytosis via Fc receptors and complement activation.
  • Antibody interaction with megakaryocytes may also impair platelet production.

    • Conclusions:

    • ITP involves autoantibodies against platelet glycoproteins, leading to platelet destruction and potentially impaired production.
    • The underlying immunoregulatory defect causing ITP is currently unidentified.